2m 2m 2m 2m 2m 2m 2m
AKANDA (AKAN)
NASDAQ
$15.63-$0.55 (-3.40%)
Price as of Jun 23, 2026 7:57 PM EDT- $8.2MMarket Cap
- -82.65%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AKANDA (AKAN)
$15.63-$0.55 (-3.40%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 79
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$14.33
$16.71
$16.18
1-Year Range
$0.45
$57.09
$16.18
Latest Close$16.18
Change
+$1.11 (+6.86%)
Volume59,098
Market Cap$8.2M
Shares Outstanding540,841
P/E (TTM)-0.001
Diluted EPS (TTM)-$14,899.95
Enterprise Value$8.8M
Information as of 06/23/2026
Company Profile
AKANDA CORP
https://www.akandacorp.com$8.2M
Market Cap
-$45.7M
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
100 King St. W, Toronto, ON, Canada, M5X 1G5
416-862-7525Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.
Key Executives
- Katharyn Field
- Gurcharn Deol
- Francisco Juarez
Current Ownership Distribution
- Mutual Funds725,529 (50.72%)
- Institutions697,158 (48.74%)
- Insiders7,816 (0.55%)
- Other0 (0.00%)